Facephi Biometria SA (ES:FACE)
BME:FACE
Want to see ES:FACE full AI Analyst Report?
FACE Stock Chart & Stats
€2.53
€0.00(0.00%)
At close: 4:00 PM EST
€2.53
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.90 - €2.88
Previous CloseN/A
Volume1.96K
Average Volume (3M)21.10K
Market Cap
€54.22M
Enterprise Value€58.74M
Total Cash (Recent Filing)€2.21M
Total Debt (Recent Filing)€7.20M
Price to Earnings (P/E)147.2
Beta0.16
Next Earnings
Oct 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding26,624,086
10 Day Avg. Volume10,893
30 Day Avg. Volume21,097
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)3.07
Price to Sales (P/S)1.86
P/FCF Ratio-47.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)€46.10M
Bulls Say, Bears Say
Bulls Say
Revenue & Profit TurnaroundA clear revenue inflection (+20.7%) alongside a return to positive EBIT and net income in 2025 signals product-market fit and scalable licensing/transaction economics. Durable revenue and profitability recovery improves internal funding ability and reduces reliance on external capital over the medium term.
Improved Operating Cash FlowMaterial improvement in operating cash flow (~€7.3M) reflects better cash conversion from operations and healthier recurring revenues. Stronger OCF supports reinvestment in product and sales motion, provides a buffer versus cyclical revenue swings, and enhances financial sustainability over coming quarters.
Lower Leverage / Better Balance SheetDeclining leverage (debt/equity ~0.33) materially improves financial flexibility and reduces interest burden risk. A stronger balance sheet enables the company to pursue strategic investments, absorb shocks, and negotiate partnerships or contracts with less financing stress over multiple quarters.
Bears Say
Thin Net ProfitabilityNet margin near 1% indicates limited ability to convert revenue growth into durable shareholder returns. Thin profits constrain retained earnings for reinvestment, make results sensitive to cost inflation or pricing pressure, and require sustained margin expansion to justify ongoing investment.
Negative Free Cash FlowPersistent negative free cash flow (~-€1.4M) shows operating cash isn't fully covering investments or working-capital needs. Over months this can force external financing, constrain strategic spending, and limit the firm's ability to scale profitably without improving cash conversion or reducing capex/working capital.
Earnings Volatility & Prior LossesRecent history of large losses and volatile results undermines forecasting reliability and raises execution risk. For customers, partners, and investors this volatility complicates contract planning and capital allocation, increasing the hurdle for sustainable long-term growth despite 2025 improvement.
Facephi Biometria SA News
FACE FAQ
What was Facephi Biometria SA’s price range in the past 12 months?
Facephi Biometria SA lowest stock price was €1.90 and its highest was €2.88 in the past 12 months.
What is Facephi Biometria SA’s market cap?
Facephi Biometria SA’s market cap is €54.22M.
When is Facephi Biometria SA’s upcoming earnings report date?
Facephi Biometria SA’s upcoming earnings report date is Oct 22, 2026 which is in 122 days.
How were Facephi Biometria SA’s earnings last quarter?
Currently, no data Available
Is Facephi Biometria SA overvalued?
According to Wall Street analysts Facephi Biometria SA’s price is currently Overvalued.
Does Facephi Biometria SA pay dividends?
Facephi Biometria SA does not currently pay dividends.
What is Facephi Biometria SA’s EPS estimate?
Facephi Biometria SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Facephi Biometria SA have?
Facephi Biometria SA has 26,624,086 shares outstanding.
What happened to Facephi Biometria SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Facephi Biometria SA?
Currently, no hedge funds are holding shares in ES:FACE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Facephi Biometria SA
Facephi Biometria, S.A. delivers advanced biometric facial recognition technology solutions, primarily targeting the banking industry across Latin America, the United States, Asia, and other international markets. The company's offerings include "Facephi Beyond Biometrics," a versatile multi-biometric platform for digital identity verification that enables clients to tailor various digital onboarding and authentication processes. "SelphID" is a digital onboarding tool designed for seamless user registration or product contracting remotely. Additionally, "Selphi" provides a biometric authentication solution for verifying user identities. Other specialized solutions from Facephi encompass Look&Phi, PhiVox, inPhinite, and SignPhi. Beyond financial services, their technology is utilized in diverse sectors such as insurance, healthcare, telecommunications, travel and transportation, public administration, shared mobility, and sporting events. Established in 2012, Facephi Biometria, S.A. is headquartered in Alicante, Spain.
Technical Analysis
Izertis SA
―
Substrate Artificial Intelligence SA
―
Airtificial Intelligence Structures SA
―
Seresco SA
―
Aplicaciones y Tratamiento de Sistemas, S.A.
―